Game-Changer for Lung Cancer Fighters

Big news for anyone battling advanced lung cancer: Datroway just got FDA approval as a new targeted treatment for people with EGFR-mutated non-small cell lung cancer (NSCLC) who’ve already tried other therapies. This drug acts like a smart missile, homing in on cancer cells and sparing more healthy ones. In trials, nearly half of patients saw their tumors shrink! If you or someone you know is running out of options, this could be a real breakthrough. Definitely worth asking your doctor about. #Health #BodyHealth #LungCancer